首页> 美国卫生研究院文献>ISRN Rheumatology >Wound Healing with Medications for Rheumatoid Arthritis in Hand Surgery
【2h】

Wound Healing with Medications for Rheumatoid Arthritis in Hand Surgery

机译:手部手术治疗类风湿关节炎的伤口愈合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Introduction. Medications used to treat rheumatoid arthritis, such as corticosteroids, disease-modifying agents (DMARDs), and injectable biological agents (anti-TNFα), may have widespread effects on wound healing. In hand surgery, it is important to balance the risks of poor wound healing from continuing a medication against the risks of a flare of rheumatoid arthritis if a drug is temporarily discontinued. Materials and Methods. A United Kingdom (UK) group of 28 patients had metacarpophalangeal joint replacement surgery in 35 hands (140 wounds). All medication for rheumatoid arthritis was continued perioperatively, except for the injectable biological agents. Results. There were no instances of wound dehiscence or deep infection and only one episode of minor superficial infection. Conclusions. We conclude that provided care is taken to identify and treat any problems promptly, it is appropriate to continue most antirheumatoid medications in the perioperative period during hand surgery to reduce the risk of destabilising the patients' overall rheumatoid disease control.
机译:介绍。用于治疗类风湿性关节炎的药物,例如皮质类固醇,疾病改善剂(DMARD)和可注射生物剂(抗TNFα),可能对伤口愈合产生广泛影响。在手外科手术中,重要的是,在暂时停药的情况下,平衡继续用药引起的伤口愈合不良的风险与类风湿性关节炎发作的风险。材料和方法。英国(UK)组28例患者进行了35只手(140例伤口)的掌指关节置换手术。除可注射的生物制剂外,所有用于类风湿关节炎的药物均在围手术期继续使用。结果。没有伤口裂开或深层感染的情况,只有一例轻微的浅表感染。结论。我们得出的结论是,只要注意及时发现和治疗任何问题,就应该在手外科手术期间的围手术期继续使用大多数抗类风湿药,以减少破坏患者总体类风湿病控制的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号